Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intracytoplasmic Morphologically Selected Sperm Injection (IMSI) Benefits in the Presence of Advanced Maternal Age: a Prospective Randomized Study

NCT01620346 is registered in ClinicalTrials.gov with Sapientiae Institute as lead sponsor.

NCT NCT01620346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01620346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intracytoplasmic Morphologically Selected Sperm Injection (IMSI) Benefits in the Presence of Advanced Maternal Age: a Prospective Randomized Study
Lead sponsor
Sapientiae Institute
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2011
Completion date
August 31, 2012
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

female infertility